| Sang H Kim, MD | |
|
1086 N Broadway Ste 240, Yonkers, NY 10701-1115 | |
| (914) 377-0300 | |
| (914) 327-2183 |
| Full Name | Sang H Kim |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 30 Years |
| Location | 1086 N Broadway Ste 240, Yonkers, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023054202 | NPI | - | NPPES |
| P2640511 | Other | OXFORD | |
| P00119072 | Other | NY | RAILROAD MEDICARE |
| 9C3981 | Other | NY | BCBS |
| 02073352 | Medicaid | NY | |
| 0D2653 | Other | ACS HEALTHNET |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 206338 (New York) | Primary |
| 207UN0901X | Nuclear Medicine - Nuclear Cardiology | 206338 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York-presbyterian Hospital | New york, NY | Hospital |
| St John's Riverside Hospital | Yonkers, NY | Hospital |
| White Plains Hospital Center | White plains, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trustees Of Columbia University In The City Of New York | 8527972546 | 1895 |
News Archive
Admedus today announced that interim study results on its Phase 1 trial of a therapeutic vaccine for Herpes Simplex Virus (HSV-2) have shown that it achieved the primary endpoint of the study by being safe in the study subjects. In addition, the study has also shown that the vaccine was able to generate a T-cell response.
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND® (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
Metabolix, Inc., a bioscience company focused on developing sustainable solutions for plastics, chemicals and energy, today announced that it has commenced a public offering of shares of its common stock pursuant to the Company's effective shelf registration statement filed with the U.S. Securities and Exchange Commission.
The state's Republicans are challenging the handling of the recent meningitis outbreak and drug test tampering allegations.
For children with attention deficit hyperactivity disorder (ADHD), possessing a variant of a gene involved in brain signaling may predict antisocial behavior and increase susceptibility to the effects of lower birth weight, according to a study in the November issue of Archives of General Psychiatry.
› Verified 2 days ago
| Entity Name | Trustees Of Columbia University In The City Of New York |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982993184 PECOS PAC ID: 8527972546 Enrollment ID: O20040407001360 |
News Archive
Admedus today announced that interim study results on its Phase 1 trial of a therapeutic vaccine for Herpes Simplex Virus (HSV-2) have shown that it achieved the primary endpoint of the study by being safe in the study subjects. In addition, the study has also shown that the vaccine was able to generate a T-cell response.
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND® (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
Metabolix, Inc., a bioscience company focused on developing sustainable solutions for plastics, chemicals and energy, today announced that it has commenced a public offering of shares of its common stock pursuant to the Company's effective shelf registration statement filed with the U.S. Securities and Exchange Commission.
The state's Republicans are challenging the handling of the recent meningitis outbreak and drug test tampering allegations.
For children with attention deficit hyperactivity disorder (ADHD), possessing a variant of a gene involved in brain signaling may predict antisocial behavior and increase susceptibility to the effects of lower birth weight, according to a study in the November issue of Archives of General Psychiatry.
› Verified 2 days ago
| Entity Name | Trustees Of Columbia University In The City Of New York Cardiology Ass |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710261656 PECOS PAC ID: 1759271612 Enrollment ID: O20120126000819 |
News Archive
Admedus today announced that interim study results on its Phase 1 trial of a therapeutic vaccine for Herpes Simplex Virus (HSV-2) have shown that it achieved the primary endpoint of the study by being safe in the study subjects. In addition, the study has also shown that the vaccine was able to generate a T-cell response.
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND® (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
Metabolix, Inc., a bioscience company focused on developing sustainable solutions for plastics, chemicals and energy, today announced that it has commenced a public offering of shares of its common stock pursuant to the Company's effective shelf registration statement filed with the U.S. Securities and Exchange Commission.
The state's Republicans are challenging the handling of the recent meningitis outbreak and drug test tampering allegations.
For children with attention deficit hyperactivity disorder (ADHD), possessing a variant of a gene involved in brain signaling may predict antisocial behavior and increase susceptibility to the effects of lower birth weight, according to a study in the November issue of Archives of General Psychiatry.
› Verified 2 days ago
| Entity Name | Trustees Of Columbia University In The City Of New York |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508266347 PECOS PAC ID: 8527972546 Enrollment ID: O20151201002613 |
News Archive
Admedus today announced that interim study results on its Phase 1 trial of a therapeutic vaccine for Herpes Simplex Virus (HSV-2) have shown that it achieved the primary endpoint of the study by being safe in the study subjects. In addition, the study has also shown that the vaccine was able to generate a T-cell response.
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND® (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
Metabolix, Inc., a bioscience company focused on developing sustainable solutions for plastics, chemicals and energy, today announced that it has commenced a public offering of shares of its common stock pursuant to the Company's effective shelf registration statement filed with the U.S. Securities and Exchange Commission.
The state's Republicans are challenging the handling of the recent meningitis outbreak and drug test tampering allegations.
For children with attention deficit hyperactivity disorder (ADHD), possessing a variant of a gene involved in brain signaling may predict antisocial behavior and increase susceptibility to the effects of lower birth weight, according to a study in the November issue of Archives of General Psychiatry.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sang H Kim, MD 630 W 168th St # 4, New York, NY 10032-3725 Ph: (212) 305-9817 | Sang H Kim, MD 1086 N Broadway Ste 240, Yonkers, NY 10701-1115 Ph: (914) 377-0300 |
News Archive
Admedus today announced that interim study results on its Phase 1 trial of a therapeutic vaccine for Herpes Simplex Virus (HSV-2) have shown that it achieved the primary endpoint of the study by being safe in the study subjects. In addition, the study has also shown that the vaccine was able to generate a T-cell response.
Elan Drug Technologies, a business unit of Elan Corporation, plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND® (aprepitant) for the treatment of cancer chemotherapy-induced nausea and vomiting.
Metabolix, Inc., a bioscience company focused on developing sustainable solutions for plastics, chemicals and energy, today announced that it has commenced a public offering of shares of its common stock pursuant to the Company's effective shelf registration statement filed with the U.S. Securities and Exchange Commission.
The state's Republicans are challenging the handling of the recent meningitis outbreak and drug test tampering allegations.
For children with attention deficit hyperactivity disorder (ADHD), possessing a variant of a gene involved in brain signaling may predict antisocial behavior and increase susceptibility to the effects of lower birth weight, according to a study in the November issue of Archives of General Psychiatry.
› Verified 2 days ago
Dr. Lawrence Fayez Neshiwat, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 944 N Broadway, Suite 205, Yonkers, NY 10701 Phone: 914-237-1941 Fax: 914-237-1950 | |
Dr. Andrew E Lan, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 1010 Central Park Ave, Yonkers, NY 10704 Phone: 914-964-4000 Fax: 914-964-4044 | |
Dr. Rajendra M Rampersaud, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 970 North Broadway Suite 209, Rajendra M Rampersaud Md, Yonkers, NY 10701 Phone: 914-965-3366 Fax: 914-965-1310 | |
Dr. Ronald B Dennett, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 73 Market St, Yonkers, NY 10710 Phone: 914-848-8085 Fax: 914-607-4771 | |
Atul M Limaye, M.D Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1010 N Broadway, Yonkers, NY 10701 Phone: 914-968-5515 | |
Jose Matos, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 31 Beechwood Ter, Yonkers, NY 10705 Phone: 914-309-0429 |